Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NO16968
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: capecitabine [Xeloda];   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5 FU

Indicates status has not been verified in more than two years